Strecker E P, Berg G, Weber H, Bohl M, Dietrich B
Abteilung für Strahlendiagnostik und Nuklearmedizin, Diakonissenkrankenhaus Karlsruhe-Rüppurr, Universität Karlsruhe.
Rofo. 1987 Dec;147(6):669-72. doi: 10.1055/s-2008-1048721.
Restenosis and occlusion are the most common reasons why transluminal balloon angioplasty may fail to provide long-term benefit. To prevent restenosis and occlusion of diseased arteries after angioplasty an arterial endoprosthesis has been developed which is positioned to the balloon of an angioplasty catheter and which consists of a stainless steel pliable and elastic tube. With the inflation of the balloon the endoprosthesis will dilate and give the arterial wall a new mechanical support. This new device has been implanted in 12 experimental dogs in arteries of different size and lumen. The longest patency rate of nine months was observed with the completely developed method.